En nuestro trabajo, la enfermedad de Graves- Basedow constituye la hiperfunción tiroidea más comúnmente observada cuyo tratamiento puede ser realizado. Abstract. JARA YORG, Jorge Antonio. Treatment of patients with Grave´s disease with I. An. Fac. Cienc. Méd. (Asunción) [online]. , vol, n Graves’ disease in children: management and review of 20 patients. Visitas .. Enfermedad de graves-Basedow en la infancia y la adolescencia: aspectos.
|Published (Last):||16 July 2010|
|PDF File Size:||4.53 Mb|
|ePub File Size:||2.12 Mb|
|Price:||Free* [*Free Regsitration Required]|
Effect of methimazole, with geaves without L-thyroxine,on remission rates in Graves’ disease. Curvas y tablas de crecimiento. The management of graves’ disease in children, with special enphasis on radioiodine treatment. Exp Clin Endocrinol Diabetes,pp.
All patients were treated with antithyroid drugs. Six boys and 43 girls between the ages of 2 and 18 years were basedoww. Curr Opin Endocrinol Diabetes, 3pp. Graves’ disease and other forms of hyperthyroidism in infants and children.
There was a problem providing the content you requested
Continuing navigation will be considered as acceptance of this use. Thyroid, 10pp. Effects of drugs on the efficacy of radioiodine I therapy in hyperthyroid patients. Indian J Pediatr, 67pp.
Late results of surgical treatment.
Tratamiento de la enfermedad de Graves Basedow. Thyroid, 9pp. Graves’ disease in children: Are you bqsedow health professional able to prescribe or dispense drugs?
An Pediatr Barc58pp. Exp Clin Endocrinol Diabetes,pp.
Enermedad Clin Endocrinol Metab, 83pp. Si continua navegando, consideramos que acepta su uso. The role of haematopoietic growth factors granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the management of drug-induced agranulocytosis.
Clin Endocrinol ; J Clin Endocrinol Metab, 82pp.
J Pediatr Endocrinol Metab, 14pp. Factors at onset predictive of lasting remission in pediatric patients with graves’ disease followed for at least three years.
Tratamiento de la enfermedad de Graves Basedow | Medicina
Crecimiento puberal de 1. Incidence of hypothyroidism long after iodine therapy for hyperthyroidism. Continuing navigation will be considered as acceptance of this use. Arch Dis Child, 78pp. Antiresorptive therapy in hyperthyroid patients: The best therapy for these patients continues to enfwrmedad debated.
Tratamiento de la enfermedad de Graves Basedow
Antithyroid Drug-Induced Hematopoietic Damage: Radioiodine in the treatment of Graves’ disease. The best therapy for these patients continues to be debated Patients and methods The medical records of 20 patients with Graves’ hyperthyroidism who were treated between and were reviewed. Enfermfdad thyroidectomy was required in three patients, and two patients were treated with radioiodine Conclusion Because few children achieve remission with medical therapy, other types of treatment surgery or radioiodine are often required.
N Eng J Med,pp. Br Med JThe epidemiology of autoimmune thyroid disease. Review of cases. yraves
Tratamiento de pacientes con Enfermedad de Graves Basedow con Iodo(I)
Ablative radioiodine therapy for hyperthyroidism: The efficacy of thyroidectomy for graves’ disease: Basedow’s hasedow and thyroid nodules.
Endocr Rev ; Modification of thyroid function induced by chronic administration of iodine inthe presence of autonomous thyroid tissue. Pediatrics,pp. World J Nucl Med.
A longitudinal study of markers of bone turnover in Graves’ disease and their value in predicting bone mineral density. Thyroid nodules in Graves’ disease: Dermopathy of Graves disease pretibial myxedema. La enfermedad de Graves-Basedow es rara en la infancia y la adolescencia. Hipertiroidismo en la enfermedad de Graves-Basedow.
Treatment of Graves’ disease in children and adolescents. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism.
N Engl J Med,pp. Ajdc,pp. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism.